0.3860
+0.0553
+(16.72%)
At close: April 17 at 4:00:01 PM EDT
0.3899
+0.00
+(1.01%)
After hours: April 17 at 7:57:01 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-36,364
-36,364
-56,180
-85,483
-30,167
Investing Cash Flow
-8,365
-8,365
11,543
-44,398
--
Financing Cash Flow
44,938
44,938
47,975
29,514
97,051
End Cash Position
49,464
49,464
49,255
45,917
146,284
Income Tax Paid Supplemental Data
47
47
26
--
--
Interest Paid Supplemental Data
3,533
3,533
3,164
975
--
Capital Expenditure
--
--
--
-86
--
Issuance of Capital Stock
44,207
44,207
46,503
--
97,062
Issuance of Debt
--
--
--
30,000
--
Repurchase of Capital Stock
-48
-48
-24
-35
--
Free Cash Flow
-36,364
-36,364
-56,180
-85,569
-30,167
12/31/2021 - 6/25/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EPIX ESSA Pharma Inc.
1.7900
+1.13%
VINC Vincerx Pharma, Inc. Common Stock
0.2750
+7.34%
SPRB Spruce Biosciences, Inc.
0.1187
-3.50%
UNCY Unicycive Therapeutics, Inc.
0.6003
+0.38%
IKNA Ikena Oncology, Inc.
1.1100
0.00%
MRSN Mersana Therapeutics, Inc.
0.3547
+5.63%
IPSC Century Therapeutics, Inc.
0.5437
+8.74%
LVTX LAVA Therapeutics N.V.
1.3100
+6.50%
OVID Ovid Therapeutics Inc.
0.2886
+6.53%
PMVP PMV Pharmaceuticals, Inc.
1.0200
+2.00%